सत्याधीशसत्याधीश
SatyaDheesh
India's Ground Truth Record
Pull to refresh
VOL. I · EST. 11.2025 
SatyaDheesh
सत्याधीश
India's Ground Truth Record
LIVE

Kerala hospitals face drug shortages as KMSCL owes pharma firms over ₹2,200 crore

GS2Polity · Governance · IR· Health policy & public health· Prelims + Mains·

Public procurement and supply chain resilience in healthcare: a GS2 Social Justice and GS3 infrastructure case study.

Why in news

Kerala hospitals are facing shortages of non-communicable disease drugs due to a ₹2,200 crore debt owed by the Kerala Medical Services Corporation Limited (KMSCL) to pharmaceutical firms.

Background

KMSCL failed to release the June supply, leading to shortages of drugs like metformin, telmasartan, and atorvastatin. Health Minister K. Muraleedharan has ordered procurement by December and proposed removing middlemen to allow direct importers in tenders.

Facts for Prelims

  • FactKMSCL owes over ₹2,200 crore to pharmaceutical firms.
  • FactShortages reported for non-communicable disease drugs including metformin, telmasartan, and atorvastatin.
  • BodyKMSCL (Kerala Medical Services Corporation Limited) is the body responsible for drug procurement in Kerala.

Prelims practice question

With reference to the drug shortage in Kerala, consider the following statements:

  1. The shortage primarily affects drugs used to treat infectious diseases.
  2. The Kerala Medical Services Corporation Limited (KMSCL) owes over ₹2,200 crore to pharmaceutical firms.
  3. The Health Minister has proposed allowing direct importers to participate in tenders.

Which of the statements given above is/are correct?

  1. (a)2 only
  2. (b)1 and 3 only
  3. (c)2 and 3 only
  4. (d)1, 2 and 3
Show answer

Answer: (c) 2 and 3 only — Statements 2 and 3 are correct. Statement 1 is incorrect: The shortage affects non-communicable disease drugs.

For Mains

Q. Examine the systemic issues in public procurement of essential medicines and suggest measures to ensure uninterrupted supply chains in state-run healthcare systems.

Dimensions to cover in your answer

  • Procurement bottleneck: Debt accumulation and delayed releases disrupting the supply of essential non-communicable disease medications.
  • Regulatory reform: Potential for direct importer participation to bypass middlemen and reduce costs.
  • Fiscal management: Impact of state-run corporation debt on the availability of life-saving drugs.

Keywords: Public Procurement · Supply Chain Management · Non-Communicable Diseases · Fiscal Deficit · Healthcare Infrastructure

Read the full news →Report a mistake in this noteSource: The Hindu ↗Also: GS3 · Industry, investment & MSMEs

More Social Justice notes

All Social Justice current affairs →

Something wrong, or something missing?

Spotted a mistake in a note, or want a topic, format or PDF that would help your preparation? Write to us. We read every mail and fix errors fast.

Report a mistake →Ask for something →[email protected]

This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.